金融界1月3日消息,有投资者在互动平台向智飞生物提问:你好,董秘,请问贵公司代理的默沙东男性HPV九价疫苗什么时候可以在中国上市?可以给个大概确切的时间表吗?公司回答表示:根据公开信息显示,默沙东正在积极开展其HPV疫苗男性适应症的相关工作,以期让产品惠及更多民众。具体进展请以审评审批部门发布的信息为准。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.